The genetic alterations of ALK are found in various hematologic and stromal malignancies, including lymphomas, lung cancer, neuroblastoma, rhabdomyosarcoma, renal cell carcinoma, inflammatory IMT, inflammatory breast cancer, and melanoma (25). This evidence concerns the gene ALK and hereditary clear cell renal cell carcinoma.